Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Clinical trial NCT00689156 · COMPLETED

Trial details

NCT number: NCT00689156
Sponsor: Danish Breast Cancer Cooperative Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2008-06-01
Primary completion: 2013-01-01
Enrollment: 2015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.